The House Energy and Commerce Committee’s Health Subcommittee passed three bills last week. The Combating Autism Reauthorization Act (H.R. 4631) would reauthorize federal research, education, and early identification and intervention programs as well as the activities of the Interagency Autism Coordinating Committee. The Improving Regulatory Transparency for New Medical Therapies Act (H.R. 4299) seeks to alter the Drug Enforcement Agency’s process for scheduling new drugs approved by the Food and Drug Administration, and the Ensuring Patient Access and Effective Drug Enforcement Act (H.R. 4709) seeks to improve enforcement efforts related to prescription drug abuse.
4 June 2014